While the protein has not been thoroughly studied in the context of cancer, TMEM106B loss-of-function is known to be associated with frontotemporal lobar degeneration, and is also repressed in the brains of Alzheimer’s patients9–12. This evidence concerns the gene TMEM106B and cancer.